ライフサイエンスコーパス: bone substitute

1 pressed alkaline phosphatase activity in the bone substitute.

2 ayers were cultured on collagen membranes or bone substitute.

3 rs react diversely to collagen membranes and bone substitute.

4 of DRFs, bone nonunion, and use of surgical bone substitute.

5 ue removal, intrabony defect was filled with bone substitutes.

6 a popular source for several of the natural bone substitutes.

7 nation with a mixture of autogenous bone and bone substitutes, 14 in association with bone substitute

8 cm(3) vs 135.4 mg/cm(3); P < .001), required bone substitutes (79.6 mg/cm(3) vs 95.5 mg/cm(3); P < .0

9 mplants placed in such situations, even with bone substitutes alone, prompted the authors of this stu

10 collars after installation and removal from bone substitute and pig maxilla.

11 ate-based materials have been widely used as bone substitutes and more recently are being exploited t

12 al regeneration has focused predominantly on bone substitutes and/or barrier membrane application to

13 Barrier membranes and bone substitute are major tools of guided tissue regener

14 conditions, even when a collagen barrier and bone substitutes are applied.

15 Osseous wound healing may be enhanced if bone substitutes are combined with autologous bone marro

16 Synthetic bone substitutes are effective, but healing is slow and

17 improved bone fill as compared to a beta-TCP bone substitute at 6 months.

18 ain DRFs, develop bone nonunion, and receive bone substitutes at surgery (P < .001).

19 layers were viable on collagen membranes and bone substitute, but microtissues were less metabolicall

20 We then engineered functional bone substitutes by culturing hiPSC-derived mesenchymal

21 Bone substitutes can be designed to replicate physiologi

22 (PA) (PPCH-PA) composite graft material as a bone substitute compared to positive and negative contro

23 or 24 hr, whereas this percentage doubled on bone substitute containing NAC.

24 ytokine levels from human osteoblasts on the bone substitute decreased by one-third or more with addi

25 flap elevation, membrane usage, and type of bone substitute employed) on the outcomes of ridge prese

26 and bone substitutes, 14 in association with bone substitutes, five using only titanium grids.

27 ts pave the way for growing patient-specific bone substitutes for reconstructive treatments of the sk

28 Because alloplastic bone substitutes generally have relatively poor osteogen

29 radiographs of thirty children with ceramic bone substitute grafting were analyzed using the softwar

30 defect randomly distributed to: 1) group 1: bone-substitute grafting control (n = 10); 2) group 2: e

31 The availability of bovine derived xenogenic bone substitutes has made it possible to avoid traumatic

32 Lack of cytocompatibility in bone substitutes impairs healing in surrounding bone.

33 ar analysis confirmed that the maturation of bone substitutes in perfusion bioreactors results in glo

34 lar ridge preservation (ARP) using different bone substitutes in terms of histological outcomes and m

35 ypothesized that a clinically used inorganic bone substitute is cytotoxic to osteoblasts due to oxida

36 f bone formation than that produced with the bone substitute materials alone or rhBMP-2/(ACS) and CL

37 ogenetic protein 2 (rhBMP-2) associated with bone substitute materials beta-tricalcium phosphate (bet

38 llagen sponge (ACS) combined with all of the bone substitute materials tested resulted in a greater a

39 a greater level of biodegradation of all the bone substitute materials tested.

40 %), and regenerative surgery procedures with bone substitute materials were chosen in 20% of the case

41 ties and be employed in clinical settings as bone substitute materials.

42 le in the tests a deantigenated collagenated bone substitute of porcine origin was used to fill the g

43 assess the effects of collagen membranes and bone substitute on cell viability, adhesion and gene exp

44 ts of GTR therapy without the use of bone or bone substitutes on Class II furcation defects.

45 aluation of resorbable membranes, and use of bone substitutes or growth factors to enhance bone regen

46 e purpose of this study was to compare three bone substitute pastes of different HA content and parti

47 conductive potential of the biphasic ceramic bone substitute (SBC) composed of beta-tricalcium phosph

48 Engineering of viable bone substitutes that can be personalized to meet specif

49 NAC alleviated cytotoxicity of the bone substitute to osteoblastic viability and function,

50 is feasible and could help predict surgical bone substitute use and the occurrence of bone nonunion

51 h the occurrence of DRFs, bone nonunion, and bone substitute use at surgical treatment were examined

52 one mineral density (BMD) is associated with bone substitute use during surgery and bone nonunion, bu

53 remain to be clarified as to the efficacy of bone substitutes used in GTR procedures.

54 r ROS levels markedly increased on and under bone substitutes, which were reduced by prior addition o

55 d IL6 were modulated in PDLC microtissues on bone substitute, while there were no significant changes

56 ely; P < 0.001) than the sites receiving the bone substitute with buffer at 6 months.